NEW YORK, Nov. 22, 2023 (GLOBE NEWSWIRE) Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of
Anavex's (AVXL) Phase 2b/3 Trial of Blarcamesine Shows Robust Clinical Efficacy and Slows Neurodegeneration streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Anavex Life Sciences (AVXL) Appoints Marwan N Sabbagh as Chair of Scientific Advisory Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of
NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegene.